All In MedTech

PMA device

Aveir DR Delivery Catheter (LSCD201)

Abbott Medical · Leadless Pacemaker (PNJ, Class III) · First FDA decision Jun 29, 2023, newest Feb 23, 2026Bradycardia and heart block

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA's data service is rate-limiting requests. Try again in a minute. The numbers below may be missing or incomplete.

FDA decisions

2

PMA pathway

Device trials

4

Naming "Aveir DR"

MAUDE reports

0

Brand "Aveir DR", since 2015

PubMed studies

29

Mentioning "Aveir DR"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Aveir DR Delivery Catheter (LSCD201)

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 0 of 2 decisions filed under this name.

FDA's records could not be loaded.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "Aveir DR", any status and sponsor, newest update first.

Open in Trial Radar
  • Abbott Medical DevicesPublic (ABT)

    NCT05932602 · 2,812 participants (planned) · Start Oct 31, 2023 · Primary completion May 2029

    Device: Aveir DR Leadless Pacemaker System; Dual Chamber Transvenous Pacemaker · For: Cardiac Pacemaker; Arrythmia; Bradycardia

    Sites: Sylmar, California

  • Abbott Medical DevicesPublic (ABT)

    NCT05252702 · 464 participants · Start Feb 2, 2022 · Primary completion Aug 2, 2023

    Device: Aveir DR Leadless Pacemaker System · For: Cardiac Pacemaker, Artificial; Cardiac Rhythm Disorder; Bradycardia

    Sites: Scottsdale, Arizona; Jonesboro, Arkansas; Little Rock, Arkansas · 78 sites in all

  • Abbott Medical DevicesPublic (ABT)

    NCT05935007 · 1,805 participants (planned) · Start Oct 31, 2023 · Primary completion Dec 31, 2030

    Device: Aveir DR Leadless Pacemaker System · For: Cardiac Pacemaker; Arrythmia; Bradycardia

    Sites: Sylmar, California

1 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Aveir DR", and for the whole product code for context.

This brand

0 reports: 0 malfunction, 0 injury, 0 death

Whole product code PNJ

0 reports: 0 malfunction, 0 injury, 0 death

Newest reports for this brand

No MAUDE reports name this brand.

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "Aveir DR"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code PNJ.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.